BCM
COCHW icon

BlueCrest Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

BlueCrest Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,000,000
Closed -$7.6K – 261
2022
Q4 		$7.6K Buy
20,000,000
+19,800,000
+9,900% +$939K ﹤0.01% 145
2022
Q3 		$13K Buy
200,000
+100,001
+100% +$9.05K ﹤0.01% 173
2022
Q2 		$12K Buy
+99,999
New +$21.4K ﹤0.01% 183

Other funds holding COCHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BlueCrest Capital Management's COCHW Position: Q1 2023 in Review

BlueCrest Capital Management sold out of Envoy Medical Warrant (COCHW) in Q1 2023, closing a stake of 20,000,000 shares — an estimated $7.6K sold.

BlueCrest Capital Management first reported a position in COCHW in Q2 2022 and held it in 3 quarters. The position peaked at $13K in Q3 2022. 62 funds tracked by Wall St. Rank hold COCHW as of Q1 2023.

  • BlueCrest Capital Management reported no remaining Envoy Medical Warrant position as of Q1 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 20,000,000 Envoy Medical Warrant shares in Q1 2023, an estimated $7.6K.
  • BlueCrest Capital Management first reported a position in Envoy Medical Warrant in Q2 2022 and held it in 3 quarters.
  • BlueCrest Capital Management's Envoy Medical Warrant position peaked at $13K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.